Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
Angela Huttner(University Hospital of Geneva), Johan W. Mouton(Canisius-Wilhelmina Ziekenhuis), Anouk E. Muller(Erasmus MC), Julia Bielicki(St George's, University of London), Michelle Clements(MRC Clinical Trials Unit at UCL), Jens Kjølseth Møller(Statens Serum Institut), J P Paccaud(Global Antibiotic Research & Development Partnership)
Cited by 263
Related Papers
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|The Lancet|2022|16k
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries
|The Lancet Global Health|2019|366
Tissue concentrations: do we ever learn?
|Journal of Antimicrobial Chemotherapy|2007|337